Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
China · Delayed Price · Currency is CNY 3.840
0.00 (0.00%)
May 12, 2026, 3:00 PM CST
SHA:603718 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -296.73 | -292.16 | 171.18 | 62.87 | 121.61 | 53.86 |
Depreciation & Amortization | 17.88 | 17.88 | 37.37 | 39.71 | 47.37 | 57.57 |
Other Amortization | 2 | 2 | 1.89 | 1.16 | 2.27 | 3.9 |
Loss (Gain) From Sale of Assets | -0.34 | -0.34 | - | -0.61 | 0.36 | -7.41 |
Asset Writedown & Restructuring Costs | 633.25 | 633.25 | 1.89 | 0.05 | 0.14 | - |
Loss (Gain) From Sale of Investments | -0.06 | -0.06 | -145.64 | -56.62 | -11.44 | -35.89 |
Provision & Write-off of Bad Debts | - | - | 3.94 | 1.03 | -0.43 | 4.95 |
Other Operating Activities | 18.48 | 4.64 | 8.17 | -4.17 | -0.53 | 10.43 |
Change in Accounts Receivable | 16.27 | 16.27 | -19.41 | 54.92 | 24.66 | -68.69 |
Change in Inventory | -4.14 | -4.14 | 9.17 | 5.76 | -3.79 | -30.32 |
Change in Accounts Payable | -17.01 | -17.01 | -59.21 | -129.71 | 117.43 | 54.76 |
Change in Other Net Operating Assets | -399.3 | -399.3 | 20.45 | 23.29 | - | - |
Operating Cash Flow | 68.11 | 58.83 | 46.47 | -8.37 | 292.91 | 43.63 |
Operating Cash Flow Growth | 61.78% | 26.60% | - | - | 571.29% | -73.98% |
Capital Expenditures | -8.96 | -12.17 | -8.39 | -7.81 | -19.85 | -37.78 |
Sale of Property, Plant & Equipment | 0.58 | 0.58 | - | 0.08 | 0.15 | 28.21 |
Cash Acquisitions | -14.1 | -21.51 | -768.33 | -2.29 | - | -31.5 |
Divestitures | - | - | -9.83 | 110.98 | - | - |
Investment in Securities | -225.87 | -69.26 | 625.23 | -277.49 | 74.62 | 63.99 |
Other Investing Activities | 50.77 | 51.1 | 199.66 | 5.43 | 11.2 | 18.62 |
Investing Cash Flow | -197.58 | -51.26 | 38.34 | -171.09 | 66.13 | 41.54 |
Short-Term Debt Issued | - | - | 837.99 | 200 | 20 | 18 |
Long-Term Debt Issued | - | 3 | - | - | - | - |
Total Debt Issued | 65 | 3 | 837.99 | 200 | 20 | 18 |
Short-Term Debt Repaid | - | - | -688.41 | -66.48 | -368.32 | -23.81 |
Long-Term Debt Repaid | - | - | -1.71 | -2.07 | -6.53 | -1.2 |
Total Debt Repaid | -39.61 | - | -690.13 | -68.55 | -374.85 | -25.01 |
Net Debt Issued (Repaid) | 25.39 | 3 | 147.86 | 131.45 | -354.85 | -7.01 |
Issuance of Common Stock | 14.46 | - | - | 66.44 | - | - |
Common Dividends Paid | -122.31 | -122.26 | -21.57 | -37.9 | -0.68 | -2.98 |
Other Financing Activities | -22.69 | -32.73 | - | - | - | 60 |
Financing Cash Flow | -105.15 | -151.99 | 126.29 | 159.99 | -355.53 | 50.01 |
Foreign Exchange Rate Adjustments | -3.01 | -2.43 | 10.3 | 0 | 0.01 | -0 |
Net Cash Flow | -237.62 | -146.84 | 221.41 | -19.46 | 3.52 | 135.18 |
Free Cash Flow | 59.16 | 46.66 | 38.08 | -16.18 | 273.06 | 5.85 |
Free Cash Flow Growth | 71.84% | 22.53% | - | - | 4564.07% | -95.62% |
Free Cash Flow Margin | 34.10% | 24.84% | 14.05% | -6.72% | 91.02% | 1.69% |
Free Cash Flow Per Share | 0.09 | 0.07 | 0.06 | -0.03 | 0.43 | 0.01 |
Cash Income Tax Paid | 22.92 | 27.27 | 23.89 | 57.7 | 16.19 | 28.94 |
Levered Free Cash Flow | 69.26 | 49.9 | 44.68 | 80.42 | 180.23 | -163.6 |
Unlevered Free Cash Flow | 69.34 | 49.9 | 48.11 | 83.79 | 186.68 | -155.87 |
Change in Working Capital | -306.38 | -306.38 | -32.33 | -51.78 | 133.55 | -43.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.